CT
DXCM icon

Cambridge Trust’s DexCom DXCM Stock Holding History

Cambridge Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$18.9K Hold
136
– – ﹤0.01% 525
2023
Q4 		$16.9K Hold
136
– – ﹤0.01% 525
2023
Q3 		$12.7K Hold
136
– – ﹤0.01% 558
2023
Q2 		$17.5K Buy
136
+100
+278% +$12.1K ﹤0.01% 542
2023
Q1 		$4.18K Hold
36
– – ﹤0.01% 688
2022
Q4 		$4K Hold
36
– – ﹤0.01% 718
2022
Q3 		$3K Hold
36
– – ﹤0.01% 746
2022
Q2 		$3K Sell
36
-284
-89% -$25.9K ﹤0.01% 778
2022
Q1 		$41K Hold
320
– – ﹤0.01% 559
2021
Q4 		$43K Buy
+320
New +$46K ﹤0.01% 554

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cambridge Trust's DXCM Position: Q1 2024 in Review

Cambridge Trust held its DexCom (DXCM) position steady in Q1 2024 at 136 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Cambridge Trust first reported a position in DXCM in Q4 2021 and has held it in 10 quarters since. The position peaked at $43K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Cambridge Trust held 136 shares of DexCom worth $18.9K as of Q1 2024.
  • Cambridge Trust left its DexCom share count unchanged in Q1 2024.
  • DexCom made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #525 holding.
  • Cambridge Trust first reported a position in DexCom in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's DexCom position peaked at $43K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.